Earnings Call · Q4 FY2023·2024-02-13

Q4 23EPS -7.83%·Rev n/aQ3 23EPS +2.80%·Rev n/aQ2 23EPS +13.79%·Rev n/aQ1 23EPS -50.00%·Rev n/a⚠ consensus missing

INCYTE CORP INCY

Ben Strain — Associate Vice President, Investor Relations

Hervé Hoppenot — Chairman, President & Chief Executive Officer

Barry Flannelly — Executive Vice President and General Manager, North America

Pablo Cagnoni — President, Head of Research & Development

Steven Stein — Executive Vice President and Chief Medical Officer

Christiana Stamoulis — Executive Vice President and Chief Financial Officer

+2.6%1d on move date+4.0% vs SPY3d+2.0%5d+1.7%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more INCY calls or request research access.

More INCY calls Browse calls Request research access